Bio-Rad Laboratories (BIO) Net Cash Flow (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Net Cash Flow of -$29.1 million for Q1 2026, down 182.91% year-over-year from $35.1 million in Q1 2025, and down 121.72% quarter-over-quarter from $134.0 million in Q4 2025.
Bio-Rad Laboratories (BIO) Net Cash Flow (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Net Cash Flow for 18 consecutive years, with -$29.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 182.91% year-over-year to -$29.1 million; the TTM figure through Mar 2026 stood at -$4.9 million (down 105.79% YoY), while the FY2025 annual figure was $59.3 million, down 22.18% from the prior year.
- Net Cash Flow eased to -$29.1 million in Q1 2026 per BIO's latest filing, from $134.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $324.6 million in Q1 2022 and bottomed at -$212.5 million in Q2 2022.
- Historically, Net Cash Flow has averaged $2.1 million across 5 years, with a median of $11.9 million in 2024.
- On a YoY basis, Net Cash Flow climbed as much as 1711.03% in 2022 and fell as far as 471.36% in 2022.
- Bio-Rad Laboratories' Net Cash Flow stood at -$65.5 million in 2022, then gained by 27.71% to -$47.4 million in 2023, then soared by 242.47% to $67.5 million in 2024, then surged by 98.52% to $134.0 million in 2025, then tumbled by 121.72% to -$29.1 million in 2026.
- Business Quant data shows BIO's Net Cash Flow at -$29.1 million in Q1 2026, $134.0 million in Q4 2025, and $25.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.86 Bn | 195.26 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 126.19 Bn | 122.72 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.36 Bn | 109.14 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 73.32 Bn | 72.78 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.72 Bn | 47.47 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.18 Bn | 22.86 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Bio-Rad Laboratories | 10.00 Bn | 8.38 Bn | 345.80 Mn | 4.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.40 Mn |
| Jun 30, 2026 | 4.40 Mn |
| Mar 31, 2026 | -29.10 Mn |
| Mar 31, 2026 | -29.10 Mn |
| Dec 31, 2025 | 134.00 Mn |
| Dec 31, 2025 | 134.00 Mn |
| Sep 30, 2025 | 25.40 Mn |
| Sep 30, 2025 | 25.40 Mn |
| Jun 30, 2025 | -135.20 Mn |
| Jun 30, 2025 | -135.20 Mn |
| Mar 31, 2025 | 35.10 Mn |
| Mar 31, 2025 | 35.10 Mn |
| Dec 31, 2024 | 67.50 Mn |
| Dec 31, 2024 | 67.50 Mn |
| Sep 30, 2024 | 11.90 Mn |
| Sep 30, 2024 | 11.90 Mn |
| Jun 30, 2024 | -29.90 Mn |
| Jun 30, 2024 | -29.90 Mn |
| Mar 31, 2024 | 26.70 Mn |
| Mar 31, 2024 | 26.70 Mn |